By Payer Type

Medicare Part B & Part D Market Analysis

Cross-industry research covering Medicare Part B & Part D across 1 market reportspanning Pharmaceuticals.

1 Reports

1 Industries

Reports Covering Medicare Part B & Part D

Medical Cold Gel Market to Reach USD 1.8 Billion by 2033 at 5.2% CAGR

Pharmaceuticals·Market: USD 1.21 Billion (2025)·CAGR: 5.2%

Medicare Part D covers outpatient Rx topical analgesics including diclofenac gel; Part B covers physician-office-administered topicals under certain conditions. CMS IRA Negotiation Office activity is currently focused on high-spend small molecules and biologics; topical cold gels are not in the near-term IRA negotiation window, providing pricing stability through 2028 (Claritas model).

16%

Market Share

5.6%

Segment CAGR

Explore More Segments

Browse all market segments across our research coverage.

View all segments